Skip to main content
SpringerLink
Log in

Effects of β-catenin on differentially expressed genes in multiple myeloma

  • Published:
Journal of Huazhong University of Science and Technology [Medical Sciences] Aims and scope Submit manuscript

Summary

This study aimed to identify the differentially expressed genes after silencing of β-catenin in multiple myeloma transduced with β-catenin shRNA. The DNA microarray dataset GSE17385 was downloaded from Gene Expression Omnibus, including 3 samples of MM1.S (human multiple myeloma cell lines) cells transduced with control shRNA and 3 samples of MM1.S cells transduced with β-catenin shRNA. Then the differentially expressed genes (DEGs) were screened by using Limma. Their underlying functions were analyzed by employing Gene Ontology and Kyoto Encyclopedia of Genes and Genomes pathway enrichment analyses. Moreover, DEGs annotation was conducted based on the databases of tumor associated genes, tumor suppressed genes and the transcriptional regulation from patterns to profiles. Furthermore, the protein-protein interaction (PPI) relationship was obtained from STRING and the protein-protein interaction network and the functional modules were visualized by Cytoscape. Then, the pathway enrichment for the DEGs in the functional module was performed. A total of 301 DEGs, including 124 up-regulated and 117 down-regulated DEGs, were screened. Functional enrichment showed that CCNB1 and CDK1 were significantly related to the function of cell proliferation. FOS and JUN were related to innate immune response-activating signal transduction. Pathway enrichment analysis indicated that CCNB1 and CDK1 were most significantly enriched in the pathway of cell cycle. Besides, FOS and JUN were significantly enriched in the Toll-like receptor signaling pathway. FOXM1 was identified as a transcription factor. Moreover, there existed interactions among CCNB1, FOXM1 and CDK1 in PPI network. The expression of FOS, JUN, CCNB1, FOXM1 and CDK1 may be affected by β-catenin in multiple myeloma.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Hideshima T, Mitsiades C, Tonon G, et al. Understanding multiple myeloma pathogenesis in the bone marrow to identify new therapeutic targets. Nat Rev Cancer, 2007,7(8):585–59

    Article  CAS  PubMed  Google Scholar 

  2. Hemdon, TM, Deisseroth A, Kaminskas E, et al. U.S. Food and Drug Administration approval: carfilzomib for the treatment of multiple myeloma. Clin Cancer Res, 2013,19(17):4559–4563

    Article  Google Scholar 

  3. Siegel R, Naishadham D, Jemal A. Cancer statistics for Hispanics/Latinos, 2012. CA Cancer J Clin, 2012,62(5):283–298

    Article  PubMed  Google Scholar 

  4. Sukhdeo K, Mani M, Zhang Y, et al. Targeting the beta-catenin/TCF transcriptional complex in the treatment of multiple myeloma. Proc Natl Acad Sci USA, 2007,104(18):7516–7521

    Article  PubMed Central  PubMed  Google Scholar 

  5. Dutta-Simmons J, Zhang Y, Gorgun G, et al. Aurora kinase A is a target of Wnt/beta-catenin involved in multiple myeloma disease progression. Blood, 2009,114(13):2699–2708

    Article  CAS  PubMed  Google Scholar 

  6. Liang W, Yang C, Qian Y, et al. Effects of short-hairpin RNA-inhibited β-catenin expression on the growth of human multiple myeloma cells in vitro and in vivo. Biochem Biophys Res Commun, 2012,422(4):681–686

    Article  CAS  PubMed  Google Scholar 

  7. Zi FM, He JS, Li Y, et al. Fibroblast activation protein protects bortezomib-induced apoptosis in multiple myeloma cells through β-catenin signaling pathway. Cancer Biol Ther, 2014,15(10):1413–1422

    Article  CAS  PubMed  Google Scholar 

  8. Narasipura SD, Henderson LJ, Fu SW, et al. Role of β-catenin and TCF/LEF family members in transcriptional activity of HIV in astrocytes. J Virol, 2012,86(4):1911–1921

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  9. Afsari B, Geman D, Fertig EJ. Learning dysregulated pathways in cancers from differential variability analysis. Cancer Inform, 2014,13:61–67

    PubMed Central  PubMed  Google Scholar 

  10. Irizarry RA, Bolstad BM, Colin F, et al. Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res, 2003,31(4):15

    Article  Google Scholar 

  11. Gentleman R. Reproducible research: a bioinformatics case study. Stat Appl Genet Mol Biol, 2005,4:2

    Google Scholar 

  12. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Series B (Methodological), 1995,57(1):289–300

    Google Scholar 

  13. Ashburner M, Ball CA, Blake JA, et al. Gene Ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet, 2000,25(1):25–29

    CAS  PubMed  Google Scholar 

  14. Ogata H, Goto S, Sato K, et al. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res, 1999,27(1):29–34

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  15. Matys V, Fricke E, Geffers R, et al. TRANSFAC: transcriptional regulation, from patterns to profiles. Nucleic Acids Res, 2003,31(1):374–378

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  16. Zhao M, Sun J, Zhao Z. TSGene: a web resource for tumor suppressor genes. Nucleic Acids Res, 2013,41(1):970–976

    Article  Google Scholar 

  17. Chen JS, Hung WS, Chan HH, et al. In silico identification of oncogenic potential of fyn-related kinase in hepatocellular carcinoma. Bioinformatics, 2013,29(4):420–427

    Article  PubMed  Google Scholar 

  18. Franceschini A, Szklarczyk D, Frankid S, et al. STRING v9.1: protein-protein interaction networks, with increased coverage and integration. Nucleic Acids Res, 2013,41(1):808–815

    Article  Google Scholar 

  19. Saito R, Smoot ME, Ono K, et al. A travel guide to Cytoscape plugins. Nat Methods, 2012,9(11):1069–1076

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  20. Beisser D, Klau GW, Dandekar T, et al. BioNet: an R-Package for the functional analysis of biological networks. Bioinformatics, 2010,26(8):1129–1130

    Article  CAS  PubMed  Google Scholar 

  21. Munshi NC, Li C, Minvielle S. Alternate splicing is a frequent event and impacts clinical outcome in myeloma: A High-density exon array analysis of uniformly treated newly-diagnosed myeloma patients. Blood, 2008,112(11):189–189

    Google Scholar 

  22. Munshi NC, Avet-Loiseau H. Genomics in multiple myeloma. Clin Cancer Res, 2011,17(6):1234–1242

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  23. Song, WH, Zhang CL, Hu YG, et al. Bone marrow microenvironment affects the pathogenesis of multiple myeloma through downregulation of alternative splicing factor FOX2 in myeloma cells. Blood, 2013,122(21):3085

    Google Scholar 

  24. Li Y, Chen YL, Xie YT, et al. Association study of germline variants in CCNB1 and CDK1 with breast cancer susceptibility, progression, and survival among Chinese Han women. PloS One, 2013,8(12):84489

    Article  Google Scholar 

  25. Dai H, Ye M, Peng M, et al. Aptamer TY04 inhibits the growth of multiple myeloma cells via cell cycle arrest. Tumor Biol, 2014,35(8):7561–7568

    Article  CAS  Google Scholar 

  26. Fu Z, Malureanu L, Huang J, et al. Plk1-dependent phosphorylation of FoxM1 regulates a transcriptional programme required for mitotic progression. Nat cell Biol, 2008,10(9):1076–1082

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  27. Oren M. Decision making by p53: life, death and cancer. Cell Death Differ, 2003,10(4):431–442

    Article  CAS  PubMed  Google Scholar 

  28. Saha MN, Jiang H, Yang Y, et al. Targeting p53 via JNK pathway: a novel role of RITA for apoptotic signaling in multiple myeloma. PloS One, 2012,7(1):30215

    Article  Google Scholar 

  29. Li X, Jiang S, Tapping RI. Toll-like receptor signaling in cell proliferation and survival. Cytokine, 2010,49(1):1–9

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  30. Bagartuni T, Kastritis E, Liacos C, et al. Toll-Like receptor activation promotes multiple myeloma cell growth and survival by suppression of endoplasmic reticulum stress factor CHOP. Blood, 2013,122(21):3112–3112

    Google Scholar 

  31. Bao H, Lu P, Li Y, et al. Triggering of toll-like receptor-4 in human multiple myeloma cells promotes proliferation and alters cell responses to immune and chemotherapy drug attack. Cancer Biol Ther, 2011,11(1):58–67

    Article  CAS  PubMed  Google Scholar 

  32. Cholujova D, Jakubikova J, Czako B, et al. MGN-3 arabinoxylan rice bran modulates innate immunity in multiple myeloma patients. Cancer Immunol Immunother, 2013,62(3):437–445

    Article  CAS  PubMed  Google Scholar 

  33. Dhodapkar MV, Geller MD, Chang DH, et al. A reversible defect in natural killer T cell function characterizes the progression of premalignant to malignant multiple myeloma. J Exp Med, 2003,197(12):1667–1676

    Article  CAS  PubMed Central  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Orthopedics, Chinese People’s Liberation Army General Hospital, Beijing, 100853, China

    Hui Chen  (陈辉), Wei Chai  (柴伟), Ming Ni  (倪明), Guo-qiang Zhang  (张国强), Hua-wei Liu  (刘华玮), Zhuo Zhang  (张卓), Ji-ying Chen  (陈继营), Yong-gang Zhou  (周勇刚) & Yan Wang  (王岩)

  2. Department of Orthopedics, Jinan Central Hospital Affiliated to Shandong University, Jinan, 250013, China

    Bin Li  (李斌)

Authors
  1. Hui Chen  (陈辉)
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Wei Chai  (柴伟)
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Bin Li  (李斌)
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ming Ni  (倪明)
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Guo-qiang Zhang  (张国强)
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Hua-wei Liu  (刘华玮)
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Zhuo Zhang  (张卓)
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Ji-ying Chen  (陈继营)
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Yong-gang Zhou  (周勇刚)
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Yan Wang  (王岩)
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yan Wang  (王岩).

Additional information

This project was supported by a grant from the National High-tech Research & Development Program (No. 2011AA030101).

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chen, H., Chai, W., Li, B. et al. Effects of β-catenin on differentially expressed genes in multiple myeloma. J. Huazhong Univ. Sci. Technol. [Med. Sci.] 35, 546–552 (2015). https://doi.org/10.1007/s11596-015-1468-4

Download citation

  • Received:

  • Revised:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11596-015-1468-4

Key words

Search

Navigation